A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)

Clinical trial NCT07170644 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07170644
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Desmoid Tumor Aggressive Fibromatosis

Start date: 2025-08-08
Primary completion: 2027-05-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.